Beverly Mitchell, MD
AML Specialist
2023 years treating Acute Myeloid Leukemia
2023 years treating Acute Myeloid Leukemia
Dr. Mitchell's current research relates to the development of new therapies for hematologic malignancies. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. Recent studies have focused on the role of nucleolar proteins in cellular stress responses, including that induced by reactive oxygen species. She is also interested in the regulation of ribosomal RNA synthesis in hematopoietic stem and progenitor cells and in the role of dysregulated synthesis in bone marrow failure syndromes. in addition, her laboratory is involved in the translation of these studies into scientifically designed clinical trials.
Stanford Comprehensive Cancer Center: 875 Blake Wilbur Dr, Palo Alto, CA 94304, USA